|
13 Nov 2019 |
Social |
RT @hausmannMD: Holy Molly! TNFi (etanercept, adalimumab, infliximab, or golimumab) completely prevented stokes in patients with DADA2. #AC… |
|
|
13 Nov 2019 |
Social |
RT @Janetbirdope: Infections In out patients are increased as measured by antimicromial scripts with RA and TNFi use comparing popn control… |
|
|
13 Nov 2019 |
Social |
RT @DrKanikaMonga: - Risk of bDMARD withdrawal higher for TNFi monotherapy
compared w/ cs/bDMARD combination
- If monotherapy necessary, et… |
|
|
10 Nov 2019 |
ACR Video |
Use of TNF Inhibitors: Dr. Olga Petryna |
|
|
30 Oct 2019 |
News |
Psoriasis Risk Increased with TNF Inhibitors in Juveniles |
|
|
28 Oct 2019 |
News |
The Shame Behind Adalimumab Biosimilars |
|
|
28 Oct 2019 |
Slide of the day |
New Biosimilars for Rheumatology - 2019 |
|
|
22 Oct 2019 |
News |
Pain Persists Despite TNF Inhibitor Use |
|
|
22 Oct 2019 |
News |
Adalimumab and Pregnancy Outcomes |
|
|
12 Aug 2019 |
News |
Enbrel Patent Battle Won by Amgen |
|
|
01 Aug 2019 |
News |
TNF Inhibitor and Biologic Induced Psoriasis |
|
|
24 Jul 2019 |
Slide of the day |
anti-TNF Biosimilars in USA |
|
|
09 May 2019 |
Social |
Analysis of claims data compared hospitalized infection rates among 11,248 matched pairs of new initiators of abatacept or TNF inhibitors. Serious hosp infections were significantly lower in ABA vs infliximab (HR 0.63; 0.47-0.85), but similar to ETN & ADA https://t.co/JhXlC7p1A7 |
|
|
29 Mar 2019 |
News |
FDA Approves Cimzia for Non-Radiographic Axial Spondyloarthritis |
|
|
13 Mar 2019 |
News |
Lower TNF Inhibitor Persistence in Spondylitis |
|
|
22 Feb 2019 |
News |
The Risk of Tuberculosis with TNF Inhibitors |
|
|
11 Feb 2019 |
ACR Video |
QD Clinic - Breast Cancer & a TNF Inhibitor |
|
|
06 Feb 2019 |
Social |
The EMAs CHMP has issued a eceived a positive opinion for 2 TNF inhibitor biosimilars: Idacio (adalimumab) and Kromeya (adalimumab). For the treatment of select inflammatory and autoimmune disorders https://t.co/lz7EvtTcTB |
|
|
24 Jan 2019 |
Social |
Using FMF-KI knockout mice (high TNF levels) researchers find TNF signaling drives pyrin & inflammasome activation; TNF is a critical modulator of pyrin of pyrin-inflammasomopathies like FMF. This is why TNF inhib sometimes work in inflammasomopathies. https://t.co/0EvuTI57tn |
|
|
19 Dec 2018 |
Social |
Study from the UK BSRBR registry shows 34 cancers & 41 deaths in 709 pts. Risk of CA w/ TNFi was not increased (SIR 0.94; 95% CI 0.65,1.34) (but for 2 fold incr risk of nonmelanoma skin CA) & all-cause mortality rate was increased (SMR 1.56) from CV events https://t.co/6HSnw5SOF8 |
|
